Results 131 to 140 of about 5,137,646 (317)
ClinicoEconomics and Outcomes Research, 2019 Kaoru Yamabe,1 Marco D DiBonaventura,2 Chris L Pashos3 1Healthcare Policy and Access, Takeda Pharmaceutical Company Limited, Chuouku, Tokyo 103-8668, Japan; 2Health Outcomes, Kantar Health, New York, NY 10010, USA; 3Global Outcomes and Epidemiology ...
Yamabe K, DiBonaventura MD, Pashos CL
doaj
Molecular Oncology, EarlyView.A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Advocate Health Care Annual Report, 2005
Advocate Health Care, Oak Brook, IL: Annual report for Advocate Health Care titled Existing to Serve: The Advocate Health Care Story . Features stories from patients about care they received at Advocate locations.
Advocate Health - Midwest
core
Facts brochure, Aurora Health Care, 1995
, 2020 Aurora Health Care, Wisconsin: A 1995 Aurora Health Care brochure with statistics and information on Aurora Medical Group, Aurora Family Care, Hartford Memorial Hospital, Lakeland Medical Center, Milwaukee Psychiatric Hospital, St Luke\u27s Medical ...
Advocate Aurora Health
core
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Advocate Health Care Annual Report, 2006
Advocate Health Care, Oak Brook, IL: Annual report for Advocate Health Care titled Impact . Includes data, statistics, and development plans for eight legacy hospitals and out-patient centers.
Advocate Health - Midwest
core
Quick Facts about Aurora Health Care, 2010
, 2016 Aurora Health Care, Wisconsin: A single sheet showing facts and statistics about Aurora Health Care as of 2010, including number of hospitals, number of caregivers, awards and honors, and technological innovations.https://institutionalrepository.aah.org ...
Advocate Aurora Health
core
Clinical Epidemiology, 2019 Irene Petersen,1,2 Catherine A Welch,3 Irwin Nazareth,1 Kate Walters,1 Louise Marston,1 Richard W Morris,4 James R Carpenter,5,6 Tim P Morris,5 Tra My Pham1 1Department of Primary Care and Population Health, University College London, London NW3 2PF, UK;
Petersen I +8 more
doaj